z-logo
Premium
Acute and fatal cephalosporin‐induced autoimmune haemolytic anaemia
Author(s) -
Boilève Alice,
Gavaud Ariane,
Grignano Eric,
Franck Nathalie,
Carlotti Agnès,
Mira JeanPaul,
Bouscary Didier,
Jozwiak Mathieu
Publication year - 2021
Publication title -
british journal of clinical pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.216
H-Index - 146
eISSN - 1365-2125
pISSN - 0306-5251
DOI - 10.1111/bcp.14612
Subject(s) - medicine , ceftriaxone , cephalosporin , pneumonia , antibiotics , surgery , dermatology , gastroenterology , microbiology and biotechnology , biology
We report the case of an 82‐year old male patient admitted in our medical intensive care unit for diffuse skin lesions, 3 days after the onset of ceftriaxone for bilateral pneumonia without microbiological documentation. The patient concomitantly exhibited diffuse skin lesions compatible with livedo and neurological and haemodynamic failure. Biological analysis revealed acute haemolytic anaemia. Warming of patient, red blood‐cells transfusion and high‐doses corticosteroids were initiated and ceftriaxone was stopped. Despite these therapeutics, the patient exhibited multiple organ failure and died. The main suspected triggering factor of this acute and fatal haemolytic anaemia was ceftriaxone administration considering: (i) the delay between cephalosporin administration and symptoms; (ii) the worsening of livedo and acrocyanosis a few hours after meningeal ceftriaxone doses; and (iii) fatal evolution. Cephalosporin‐induced autoimmune haemolytic anaemia is a rare and serious cause of livedo that should be suspected in patients exhibiting livedo and acute haemolytic anaemia within hours/days following cephalosporin administration.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here